IN2013MU03216A - - Google Patents

Info

Publication number
IN2013MU03216A
IN2013MU03216A IN3216MU2013A IN2013MU03216A IN 2013MU03216 A IN2013MU03216 A IN 2013MU03216A IN 3216MU2013 A IN3216MU2013 A IN 3216MU2013A IN 2013MU03216 A IN2013MU03216 A IN 2013MU03216A
Authority
IN
India
Prior art keywords
compounds
preventing
formula
preparation
disclosed
Prior art date
Application number
Other languages
English (en)
Inventor
Prasad Keshav Deshpande
Shivaji Sampatrao Pawar
Satish Bhavsar
Ravindra Dattatraya Yeole
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to JP2016521668A priority Critical patent/JP6411482B2/ja
Priority to PCT/IB2014/065195 priority patent/WO2015052682A1/fr
Priority to CA2926773A priority patent/CA2926773A1/fr
Priority to CN201480066216.6A priority patent/CN106414444B/zh
Priority to EP14802150.4A priority patent/EP3055311B1/fr
Priority to AU2014333436A priority patent/AU2014333436A1/en
Priority to IN3216MU2013 priority patent/IN2013MU03216A/en
Priority to MX2016004509A priority patent/MX2016004509A/es
Priority to US15/027,790 priority patent/US9434728B1/en
Priority to RU2016113755A priority patent/RU2016113755A/ru
Publication of IN2013MU03216A publication Critical patent/IN2013MU03216A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3216MU2013 2013-10-11 2014-10-10 IN2013MU03216A (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2016521668A JP6411482B2 (ja) 2013-10-11 2014-10-10 窒素含有化合物およびその使用
PCT/IB2014/065195 WO2015052682A1 (fr) 2013-10-11 2014-10-10 Composés azotés et leur utilisation
CA2926773A CA2926773A1 (fr) 2013-10-11 2014-10-10 Composes azotes et leur utilisation
CN201480066216.6A CN106414444B (zh) 2013-10-11 2014-10-10 含氮化合物以及它们的用途
EP14802150.4A EP3055311B1 (fr) 2013-10-11 2014-10-10 Composés azotés et leur utilisation
AU2014333436A AU2014333436A1 (en) 2013-10-11 2014-10-10 Nitrogen containing compounds and their use
IN3216MU2013 IN2013MU03216A (fr) 2013-10-11 2014-10-10
MX2016004509A MX2016004509A (es) 2013-10-11 2014-10-10 Compuestos que contienen nitrogeno y su uso.
US15/027,790 US9434728B1 (en) 2013-10-11 2014-10-10 Nitrogen containing compounds and their use
RU2016113755A RU2016113755A (ru) 2013-10-11 2014-10-10 Азотсодержащие соединения и их применение

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3216MU2013 IN2013MU03216A (fr) 2013-10-11 2014-10-10

Publications (1)

Publication Number Publication Date
IN2013MU03216A true IN2013MU03216A (fr) 2015-07-03

Family

ID=51945946

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3216MU2013 IN2013MU03216A (fr) 2013-10-11 2014-10-10

Country Status (10)

Country Link
US (1) US9434728B1 (fr)
EP (1) EP3055311B1 (fr)
JP (1) JP6411482B2 (fr)
CN (1) CN106414444B (fr)
AU (1) AU2014333436A1 (fr)
CA (1) CA2926773A1 (fr)
IN (1) IN2013MU03216A (fr)
MX (1) MX2016004509A (fr)
RU (1) RU2016113755A (fr)
WO (1) WO2015052682A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014MU00858A (fr) 2014-03-14 2015-09-25 Wockhardt Ltd
WO2018053057A2 (fr) * 2016-09-19 2018-03-22 Merck Sharp & Dohme Corp. Procédé de préparation d'intermédiaires d'hydroxyurée inhibiteurs des bêta-lactamases
JOP20190061A1 (ar) * 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
CN111138456A (zh) * 2019-12-27 2020-05-12 山东安弘制药有限公司 一种头霉素中间体化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
EP3260551A1 (fr) * 2008-06-19 2017-12-27 Astra Zeneca Holding France Utilisation de (1r, 2s, 5r) 1,6-diazabicyclo [3.2.1] octane-2-carboxamide, 7-oxo-6-(sulfooxy) -, sel monosodique en tant que réactif de diagnostic pour la détection de sérines bêta-lactamases
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
AU2012310136B2 (en) * 2011-09-13 2016-07-07 Wockhardt Limited Nitrogen containing compounds and their use

Also Published As

Publication number Publication date
EP3055311A1 (fr) 2016-08-17
JP2016532661A (ja) 2016-10-20
JP6411482B2 (ja) 2018-10-24
RU2016113755A3 (fr) 2018-06-26
EP3055311B1 (fr) 2017-08-09
CN106414444A (zh) 2017-02-15
US9434728B1 (en) 2016-09-06
WO2015052682A1 (fr) 2015-04-16
CA2926773A1 (fr) 2015-04-16
CN106414444B (zh) 2018-02-02
AU2014333436A1 (en) 2016-05-05
RU2016113755A (ru) 2017-11-16
MX2016004509A (es) 2016-10-28
US20160257684A1 (en) 2016-09-08

Similar Documents

Publication Publication Date Title
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
PH12016501512B1 (en) Treatment for resistant acne
PH12016500207A1 (en) Anti-infective compounds
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
MX2015002177A (es) Derivados de 1,6- diazabiciclo [3.2,1] octano-7-ona y su uso en el tratamiento de las infecciones bacterianas.
PH12016500453A1 (en) Antimicrobial compounds and methods of making and using the same
MX2015010125A (es) Derivados de piridazinona-amidas.
MX2016006432A (es) Tetrahidro-benzodiazepinonas.
MY173518A (en) Antimicrobial compounds and methods of making and using the same
WO2015003816A3 (fr) Cystobactamides
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
EP2953624A4 (fr) Procédés de traitement d'infections microbiennes, y compris la mammite
MX2016009248A (es) Compuestos que contienen nitrogeno y su uso como agentes antibacterianos.
MX363678B (es) Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
EA030204B8 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
AU2015352440B2 (en) Compounds
PH12017501071A1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
ZA201503474B (en) Compositions and methods for treating bacterial infections
MX2015005753A (es) Agentes antimicrobianos.
IN2013MU03216A (fr)
MX356102B (es) Compuestos y métodos para tratar leucemia.
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
AU2013900412A0 (en) Methods Of Treating Microbial Infections, Including Skin Infections